tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MIST Stock Latest News

Milestone Pharmaceuticals upgraded to Buy at TD Cowen after Cardamyst approval
The FlyMilestone Pharmaceuticals upgraded to Buy at TD Cowen after Cardamyst approval
4h ago
MIST
Milestone Pharmaceuticals upgraded to Buy from Hold at TD Cowen
PremiumThe Fly
Milestone Pharmaceuticals upgraded to Buy from Hold at TD Cowen
4h ago
MIST
Milestone Pharmaceuticals Poised for Success with Cardamyst Approval and Strong Market Potential
PremiumRatings
Milestone Pharmaceuticals Poised for Success with Cardamyst Approval and Strong Market Potential
4h ago
MIST
Milestone Pharmaceuticals price target raised to $8 from $5 at H.C. Wainwright
PremiumThe Fly
Milestone Pharmaceuticals price target raised to $8 from $5 at H.C. Wainwright
4h ago
MIST
Milestone Pharmaceuticals Gains FDA Approval for CARDAMYST
PremiumCompany Announcements
Milestone Pharmaceuticals Gains FDA Approval for CARDAMYST
5h ago
8K
MIST
Milestone Pharmaceuticals receives FDA approval of CARDAMYST
PremiumThe FlyMilestone Pharmaceuticals receives FDA approval of CARDAMYST
1d ago
MIST
Milestone Pharmaceuticals trading halted, news pending
Premium
The Fly
Milestone Pharmaceuticals trading halted, news pending
3d ago
MIST
Milestone Pharmaceuticals: Buy Rating Reaffirmed Amid Imminent PDUFA Date and Misunderstood CRL Implications
Premium
Ratings
Milestone Pharmaceuticals: Buy Rating Reaffirmed Amid Imminent PDUFA Date and Misunderstood CRL Implications
10d ago
MIST
Milestone Pharmaceuticals Reports Q3 2025 Financial Results
PremiumCompany Announcements
Milestone Pharmaceuticals Reports Q3 2025 Financial Results
1M ago
MIST
Milestone Pharmaceuticals Prepares for CARDAMYST Launch Amid Financial Growth
PremiumCompany Announcements
Milestone Pharmaceuticals Prepares for CARDAMYST Launch Amid Financial Growth
1M ago
MIST
Milestone Pharmaceuticals: Positioned for Success with Cardamyst’s Potential Approval and Launch
PremiumRatings
Milestone Pharmaceuticals: Positioned for Success with Cardamyst’s Potential Approval and Launch
1M ago
MIST
Milestone Pharmaceuticals reports Q3 EPS (12c), consensus (17c)
PremiumThe Fly
Milestone Pharmaceuticals reports Q3 EPS (12c), consensus (17c)
1M ago
MIST
MIST Earnings this Week: How Will it Perform?
PremiumPre-EarningsMIST Earnings this Week: How Will it Perform?
1M ago
MIST
Milestone Pharmaceuticals to present new analysis from trials for PSVT
Premium
The Fly
Milestone Pharmaceuticals to present new analysis from trials for PSVT
1M ago
MIST
Milestone Pharmaceuticals initiated with an Overweight at Wells Fargo
Premium
The Fly
Milestone Pharmaceuticals initiated with an Overweight at Wells Fargo
3M ago
MIST
Milestone Pharmaceuticals Reports Increased Loss Amid R&D Focus
PremiumCompany Announcements
Milestone Pharmaceuticals Reports Increased Loss Amid R&D Focus
4M ago
MIST
Milestone Pharmaceuticals: Strong Buy Rating Backed by Anticipated Cardamyst Approval and Robust Financial Position
PremiumRatings
Milestone Pharmaceuticals: Strong Buy Rating Backed by Anticipated Cardamyst Approval and Robust Financial Position
4M ago
MIST
Milestone Pharmaceuticals Advances CARDAMYST with FDA and Financial Boost
PremiumCompany Announcements
Milestone Pharmaceuticals Advances CARDAMYST with FDA and Financial Boost
4M ago
MIST
Milestone Pharmaceuticals reports Q2 EPS (20c), consensus (18c)
PremiumThe Fly
Milestone Pharmaceuticals reports Q2 EPS (20c), consensus (18c)
4M ago
MIST
Milestone Pharmaceuticals’ Cardamyst NDA Resubmission Boosts Buy Rating Amid FDA Progress
PremiumRatingsMilestone Pharmaceuticals’ Cardamyst NDA Resubmission Boosts Buy Rating Amid FDA Progress
5M ago
MIST
Milestone Pharmaceuticals Announces Public Offering for $48.7M
Premium
Company Announcements
Milestone Pharmaceuticals Announces Public Offering for $48.7M
5M ago
8K
MIST
Why Is Milestone Pharmaceuticals Stock (MIST) Down 30% Today?
Premium
Market News
Why Is Milestone Pharmaceuticals Stock (MIST) Down 30% Today?
5M ago
MIST

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >